Herbalife (NYSE:HLF) Posts Earnings Results, Beats Estimates By $0.02 EPS

Herbalife (NYSE:HLF) issued its earnings results on Wednesday. The company reported $0.45 earnings per share for the quarter, beating the consensus estimate of $0.43 by $0.02, FiscalAI reports. The business had revenue of $1.28 billion for the quarter, compared to analyst estimates of $1.24 billion. Herbalife had a net margin of 6.47% and a negative return on equity of 29.84%.

Herbalife Trading Up 3.7%

Shares of HLF traded up $0.58 during mid-day trading on Wednesday, hitting $16.52. 3,507,756 shares of the company traded hands, compared to its average volume of 1,582,307. The stock has a market capitalization of $1.71 billion, a price-to-earnings ratio of 5.28 and a beta of 0.84. The business has a 50-day moving average of $15.33 and a 200 day moving average of $11.56. Herbalife has a one year low of $5.57 and a one year high of $17.93.

Institutional Investors Weigh In On Herbalife

Several hedge funds and other institutional investors have recently made changes to their positions in the company. Brooklyn Investment Group bought a new position in Herbalife in the fourth quarter valued at about $355,000. Algert Global LLC raised its holdings in Herbalife by 55.1% during the 3rd quarter. Algert Global LLC now owns 39,339 shares of the company’s stock worth $332,000 after purchasing an additional 13,980 shares during the last quarter. Oxford Asset Management LLP acquired a new position in Herbalife during the 4th quarter valued at about $302,000. Empowered Funds LLC lifted its position in Herbalife by 12.9% during the 1st quarter. Empowered Funds LLC now owns 30,301 shares of the company’s stock valued at $261,000 after purchasing an additional 3,474 shares during the period. Finally, Sender Co & Partners Inc. bought a new position in shares of Herbalife in the 2nd quarter valued at about $194,000.

Wall Street Analysts Forecast Growth

Several research firms have recently weighed in on HLF. Argus set a $15.00 price objective on Herbalife in a research note on Wednesday, November 26th. Wall Street Zen upgraded Herbalife from a “hold” rating to a “buy” rating in a research note on Friday, November 28th. Citigroup restated a “buy” rating and issued a $17.00 target price (up previously from $11.00) on shares of Herbalife in a research note on Friday, December 12th. Mizuho set a $13.00 target price on shares of Herbalife and gave the stock a “neutral” rating in a report on Thursday, January 8th. Finally, Maxim Group began coverage on shares of Herbalife in a research report on Tuesday, January 6th. They set a “buy” rating and a $20.00 target price for the company. Four investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $15.80.

Herbalife Company Profile

Herbalife Nutrition Ltd. (NYSE: HLF) operates as a global multi-level marketing company specializing in weight-management, nutritional supplement, sports nutrition and personal care products. Its portfolio includes protein shakes, vitamins, energy and fitness supplements, hydration products and skin and hair care items, all formulated to support wellness, performance and healthy living. Products are manufactured in GMP-certified facilities to ensure consistent quality and safety standards.

Founded in 1980 by Mark R.